In focus · trending topic

FDA Regenerative Medicine

1 stories · following the connections

Mesoblast Receives FDA Regenerative Medicine Advanced Therapy Designation for Its Cell Therapy in Heart Failure Patients With Left Ventricular Assist Devices

By Nasdaq OMXDec 21, 2017, 11:00 AM UTC